Predicted protein targets (top 4)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TLR4 | O00206 | 8/20 | 0.49 |
| ▸ | LY96 | Q9Y6Y9 | 6/20 | 0.48 |
| ▸ | LGALS8 | O00214 | 2/20 | 0.47 |
| ▸ | TK2 | O00142 | 2/20 | 0.47 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Heptane SCHEMBL8771598 | 1.00 | TLR4 (0.49) | TLR4LY96LGALS8TK2 | |
| SCHEMBL8822080 | 1.00 | TLR4 (0.49) | TLR4LY96LGALS8TK2 | |
| SCHEMBL8822072 | 1.00 | TLR4 (0.49) | TLR4LY96LGALS8TK2 | |
| SCHEMBL9346790 | 1.00 | TLR4 (0.49) | TLR4LY96LGALS8TK2 | |
| SCHEMBL8195199 | 1.00 | TLR4 (0.49) | TLR4LY96LGALS8TK2 | |
| SCHEMBL4626068 | 1.00 | TLR4 (0.49) | TLR4LY96LGALS8TK2 | |
| SCHEMBL9347504 | 1.00 | TLR4 (0.49) | TLR4LY96LGALS8TK2 | |
| SCHEMBL9342585 | 0.94 | TLR4 (0.54) | TLR4LY96TK2 | |
| SCHEMBL11504109 | 0.93 | TLR4 (0.49) | TLR4LY96TK2 | |
| SCHEMBL6269517 | 0.93 | TLR4 (0.51) | TLR4LY96 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 21 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0799235-A1 | METHODS FOR THE PREPARATION OF PURE HOMOLOGOUS SERIES OF MONO TO TETRA FATTY ACYL ESTERS OF SUGARS; CHARACTERIZATION OF ONE ANTITUMOR COMPONENT AS MALTOSE 1, 6, 6' TRIPALMITATE: AND PHARMACEUTICAL FORMULATIONS USEFUL IN THE TREATMENT OF CANCER. | Université de Sherbrooke (CA) | 1997-10-08 | — | — | EP | claimed |
| US-5625044-A | ANTIGROWTH AGENTS FOR CANCER CELLS | GOUDREAU GAGE DUBEC & MARTINEAU | 1997-04-29 | — | — | US | claimed |
| WO-1996018632-A1 | METHODS FOR THE PREPARATION OF PURE HOMOLOGOUS SERIES OF MONO TO TETRA FATTY ACYL ESTERS OF SUGARS; CHARACTERIZATION OF ONE ANTITUMOR COMPONENT AS MALTOSE 1, 6, 6' TRIPALMITATE: AND PHARMACEUTICAL FORMULATIONS USEFUL IN THE TREATMENT OF CANCER. | UNIVERSITE DE SHERBROOKE (CA) | 1996-06-20 | — | — | WO | claimed |
| CN-101450957-A | Method for synthesizing maltose fatty acid ester by microwave | UNIV TIANJIN SCIENCE & TECH (CN) | 2009-06-10 | — | — | CN | disclosed |
| CN-1323086-C | Method for synthesizing fatty ester of maltose | UNIV TIANJIN SCIENCE & TECH (CN) | 2007-06-27 | — | — | CN | disclosed |
| EP-0799235-A1 | METHODS FOR THE PREPARATION OF PURE HOMOLOGOUS SERIES OF MONO TO TETRA FATTY ACYL ESTERS OF SUGARS; CHARACTERIZATION OF ONE ANTITUMOR COMPONENT AS MALTOSE 1, 6, 6' TRIPALMITATE: AND PHARMACEUTICAL FORMULATIONS USEFUL IN THE TREATMENT OF CANCER. | Université de Sherbrooke (CA) | 1997-10-08 | — | — | EP | disclosed |
| US-5625044-A | ANTIGROWTH AGENTS FOR CANCER CELLS | GOUDREAU GAGE DUBEC & MARTINEAU | 1997-04-29 | — | — | US | disclosed |
| WO-1996018632-A1 | METHODS FOR THE PREPARATION OF PURE HOMOLOGOUS SERIES OF MONO TO TETRA FATTY ACYL ESTERS OF SUGARS; CHARACTERIZATION OF ONE ANTITUMOR COMPONENT AS MALTOSE 1, 6, 6' TRIPALMITATE: AND PHARMACEUTICAL FORMULATIONS USEFUL IN THE TREATMENT OF CANCER. | UNIVERSITE DE SHERBROOKE (CA) | 1996-06-20 | — | — | WO | disclosed |
| EP-0225774-B1 | Process for preparing derivatives of maltose | HAYASHIBARA BIOCHEM LAB (JP) | 1994-07-27 | — | — | EP | disclosed |
| US-4683299-A | ESTERIFICATION WITH ACID CHLORIDES | NEBRASKA DEPARTMENT OF ECONOMIC DEVELOPMENT (US) | 1987-07-28 | — | — | US | disclosed |
| EP-0225774-A2 | Process for preparing derivatives of maltose | KABUSHIKI KAISHA HAYASHIBARA SEIBUTSU KAGAKU KENKYUJO (JP) | 1987-06-16 | — | — | EP | disclosed |
| US-4148893-A | SUGAR ESTER AND DIALKYL SULFOXIDE ENHANCE PENETRATION THROUGH SKIN | THE PROCTER & GAMBLE COMPANY (US) | 1979-04-10 | — | — | US | disclosed |
| US-4148924-A | Dermatological compositions | THE PROCTER & GAMBLE COMPANY (US) | 1979-04-10 | — | — | US | disclosed |
| US-4148874-A | ENHANCE PENETRATION OF PHARMOCOLOGICALLY ACTIVE AGENTS THROUGH THE SKIN | THE PROCTER & GAMBLE COMPANY (US) | 1979-04-10 | — | — | US | disclosed |
| US-4148887-A | SUGAR ESTER WITH A METHYL SULFOXIDE | THE PROCTER & GAMBLE COMPANY (US) | 1979-04-10 | — | — | US | disclosed |
| US-4148917-A | PENETRATION | THE PROCTER & GAMBLE COMPANY (US) | 1979-04-10 | — | — | US | disclosed |
| US-4130667-A | A SUCROSE ESTER AND A PHOSPHINE OXIDE | THE PROCTER & GAMBLE COMPANY (US) | 1978-12-19 | — | — | US | disclosed |
| US-4130643-A | STEROID, SUCROSE ESTER, SULFOXIDE | THE PROCTER & GAMBLE COMPANY (US) | 1978-12-19 | — | — | US | disclosed |
| US-4046886-A | SUGAR ESTER, PHOSPHINE OXIDE | THE PROCTER & GAMBLE COMPANY (US) | 1977-09-06 | — | — | US | disclosed |
| US-3952099-A | MICROBIOCIDE, SUGAR ESTER, SULFOXIDE | THE PROCTER & GAMBLE COMPANY (US) | 1976-04-20 | — | — | US | disclosed |